Yeu‐Chin Chen
- Hematology top 10%
- Platelet Disorders and Treatments 12
- Hemophilia Treatment and Research 10
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 6
- Blood groups and transfusion 4
-
- Chronic Lymphocytic Leukemia Research 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
-
- Heparin-Induced Thrombocytopenia and Thrombosis 5
- Co-authors
- Shin‐Nan ChengChing‐Liang HoPing‐Ying ChangRu‐Yu PanTzu‐Chuan HuangTsung‐Ying LiYi‐Ying WuLiang‐Cheng Chen
- Cited by
- HematologyGeneticsInternal Medicine
- Partner nations
- TaiwanUnited StatesSwitzerland
In The Last Decade
Yeu‐Chin Chen
46 papers receiving 306 citations
Peers
Comparison fields: 5 of 56
- Hematology 136
- Genetics 46
- Internal Medicine 12
- Pathology and Forensic Medicine 38
- Neurology 32
Countries citing papers authored by Yeu‐Chin Chen
This map shows the geographic impact of Yeu‐Chin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeu‐Chin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeu‐Chin Chen more than expected).
Fields of papers citing papers by Yeu‐Chin Chen
This network shows the impact of papers produced by Yeu‐Chin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeu‐Chin Chen. The network helps show where Yeu‐Chin Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yeu‐Chin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 16 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 17 | |
| 9 | 2021 | 7 | |
| 10 | 2019 | 22 | |
| 11 | 2017 | 1 | |
| 12 | 2015 | 7 | |
| 13 | 2015 | 7 | |
| 14 | 2015 | 7 | |
| 15 | 2013 | 11 | |
| 16 | 2013 | 5 | |
| 17 | 2011 | 5 | |
| 18 | 2010 | 10 | |
| 19 | 2009 | 17 | |
| 20 | 2009 | 2 |
About Yeu‐Chin Chen
Yeu‐Chin Chen is a scholar working on Hematology, Genetics, Internal Medicine, Emergency Medicine and Oncology, having authored 55 papers that have together received 313 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (12 papers), Hemophilia Treatment and Research (10 papers), Chronic Myeloid Leukemia Treatments (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Blood groups and transfusion (4 papers). The work is most often cited by research in Hematology (136 citations), Genetics (46 citations), Internal Medicine (12 citations), Pathology and Forensic Medicine (38 citations) and Neurology (32 citations). Yeu‐Chin Chen has collaborated with scholars based in Taiwan, United States and Switzerland. Frequent co-authors include Shin‐Nan Cheng, Ching‐Liang Ho, Ping‐Ying Chang, Ru‐Yu Pan, Tzu‐Chuan Huang, Tsung‐Ying Li, Yi‐Ying Wu, Liang‐Cheng Chen, Ming‐Shen Dai and Tsu‐Yi Chao. Their work appears in journals such as Blood, Medicine, European Journal Of Haematology, Haemophilia and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.